Advertisement

Topics

Silicon Therapeutics Appoints Todd J. Martinez, Ph.D to Scientific Advisory Board

16:23 EDT 29 Jun 2017 | Biotech-Finances

Thursday, June 29th 2017 at 7:00pm UTC Appointment strengthens focus on applying quantum mechanical methods to metalloprotein-targeted drug design BOSTON–(BUSINESS WIRE)– Silicon Therapeutics (STX), an integrated computational drug discovery company creating novel small molecule drugs for difficult to target proteins, today announced the appointment of Todd J. Martinez, PhD, Ehrsam and Franklin Professor of Chemistry

Cet article Silicon Therapeutics Appoints Todd J. Martinez, Ph.D to Scientific
Advisory Board
est apparu en premier sur EEI-BIOTECHFINANCES.

Original Article: Silicon Therapeutics Appoints Todd J. Martinez, Ph.D to Scientific Advisory Board

NEXT ARTICLE

More From BioPortfolio on "Silicon Therapeutics Appoints Todd J. Martinez, Ph.D to Scientific Advisory Board"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...